Others titles
- DEA Schedule Controlled Substance List
- SPL Validation Files for DEA Schedule
Keywords
- Structured Products Label
- SPL
- Drug Dictionary
- Pharmaceutical Dictionary
- Drug Names
- Method Validation
- Drug Label
- Drug Enforcement Administration
DEA Controlled Substance Validation Procedure
This dataset is a Structured Product Labeling (SPL) Terminology File for SPL validation procedures and contains information on performing SPL validation regarding DEA (Drug Enforcement Administration) Controlled Substance List.
Get The Data
- ResearchNon-Commercial, Share-Alike, Attribution Free Forever
- CommercialCommercial Use, Remix & Adapt, White Label Log in to download
Description
Validation procedures can be used by humans as check-lists to verify if their submission is correct. These are written specific and operational so that they may be checked by systems processing SPL documents.
The Validation Procedures for DEA Schedule are as follows:
– If the product item code (NDC) is on the DEA Exempt Products List, then there is no DEA schedule.
– If there is a DEA schedule, then the code system is 2.16.840.1.113883.3.26.1.1
– Display name matches the code
– The policy element has a class code of ‘DEADrugSchedule’.
– If the product item code (NDC) is not on the DEA Exempt Products List, then the DEA Schedule matches the one in the Controlled Substance Table where all supplied constraints match.
About this Dataset
Data Info
Date Created | 2016-12-01 |
---|---|
Last Modified | 2022-08-17 |
Version | 2022-08-17 |
Update Frequency |
Irregular |
Temporal Coverage |
N/A |
Spatial Coverage |
United States |
Source | John Snow Labs; US Food & Drug Administration (FDA); |
Source License URL | |
Source License Requirements |
N/A |
Source Citation |
N/A |
Keywords | Structured Products Label, SPL, Drug Dictionary, Pharmaceutical Dictionary, Drug Names, Method Validation, Drug Label, Drug Enforcement Administration |
Other Titles | DEA Schedule Controlled Substance List, SPL Validation Files for DEA Schedule |
Data Fields
Name | Description | Type | Constraints |
---|---|---|---|
Controlled_Substance_Name | Name of Controlled Substance | string | - |
Controlled_Substance_UNII | Controlled Substance Unique Ingredient Identifier (UNII) | string | - |
Other_Substance_Name | Name of other substance/ingredient | string | - |
Other_Substance_UNII | Other ingredient's Unique Ingredient Identifier | string | - |
Dosage_Form_Name | Available forms of presentation | string | - |
Dosage_Form_Code | Codes for the forms of presentation | string | - |
Route_of_Administration | Route of administration | string | - |
Route_of_Administration_Code | Code for the route of administration | string | - |
Lowest_Strength | Low ingredient strength | number | level : Ratio |
Highest_Strength | High ingredient strength | string | level : Ratio |
Unit_of_Strength | Mass units for ingredient strength | string | - |
DEA_Schedule_Name | Corresponding DEA Schedule | string | - |
DEA_Schedule_Code | Code of the DEA Schedule | string | - |
Data Preview
Controlled Substance Name | Controlled Substance UNII | Other Substance Name | Other Substance UNII | Dosage Form Name | Dosage Form Code | Route of Administration | Route of Administration Code | Lowest Strength | Highest Strength | Unit of Strength | DEA Schedule Name | DEA Schedule Code |
Amobarbital | GWH6IJ239E | Injection; Powder; Injection, Powder, Lyophilized, for Solution | C42946|C42972|C42957 | CII | C48675 | |||||||
Amobarbital Sodium | G0313KNC7D | Injection; Powder; Injection, Powder, Lyophilized, for Solution | C42946|C42972|C42957 | CII | C48675 | |||||||
Amobarbital | GWH6IJ239E | Suppository | C42993 | CIII | C48676 | |||||||
Amobarbital Sodium | G0313KNC7D | Suppository | C42993 | CIII | C48676 | |||||||
Dextropropoxyphene | S2F83W92TK | Tablet; Tablet, film coated; Capsule | C42998|C42931|C25158 | CIV | C48677 | |||||||
Dextropropoxyphene Hydrochloride | CB2TL9PS0T | Tablet; Tablet, film coated; Capsule | C42998|C42931|C25158 | CIV | C48677 | |||||||
Dextropropoxyphene Napsylate | 38M219L10J | Tablet; Tablet, film coated; Capsule | C42998|C42931|C25158 | CIV | C48677 | |||||||
Dextropropoxyphene Pamoate | MO8EO075MI | Tablet; Tablet, film coated; Capsule | C42998|C42931|C25158 | CIV | C48677 | |||||||
Dextropropoxyphene | S2F83W92TK | Powder | C42972 | CII | C48675 | |||||||
Dextropropoxyphene Hydrochloride | CB2TL9PS0T | Powder | C42972 | CII | C48675 |